avrg: GSE58827: Dynamics of the Mouse Liver
Gene Symbol | Gene ID | Gene Info |
---|---|---|
Elf3
|
ENSMUSG00000003051.7 | E74-like factor 3 |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
Elf3 | mm10_v2_chr1_-_135258449_135258472 | 0.65 | 1.6e-05 | Click! |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
5.0 | 15.0 | GO:0002149 | hypochlorous acid metabolic process(GO:0002148) hypochlorous acid biosynthetic process(GO:0002149) |
3.7 | 14.6 | GO:0002752 | cell surface pattern recognition receptor signaling pathway(GO:0002752) |
1.9 | 15.3 | GO:0038028 | insulin receptor signaling pathway via phosphatidylinositol 3-kinase(GO:0038028) |
1.3 | 5.4 | GO:0035470 | positive regulation of vascular wound healing(GO:0035470) |
1.2 | 3.5 | GO:0033624 | negative regulation of integrin activation(GO:0033624) |
1.1 | 3.2 | GO:0071460 | cellular response to cell-matrix adhesion(GO:0071460) |
1.1 | 4.2 | GO:1903575 | cornified envelope assembly(GO:1903575) |
1.0 | 5.2 | GO:0080154 | regulation of fertilization(GO:0080154) |
1.0 | 8.0 | GO:0097210 | response to gonadotropin-releasing hormone(GO:0097210) cellular response to gonadotropin-releasing hormone(GO:0097211) |
1.0 | 15.6 | GO:0070493 | thrombin receptor signaling pathway(GO:0070493) |
0.9 | 4.7 | GO:0042891 | antibiotic transport(GO:0042891) |
0.9 | 2.6 | GO:0002358 | B cell homeostatic proliferation(GO:0002358) |
0.9 | 6.9 | GO:0045743 | positive regulation of fibroblast growth factor receptor signaling pathway(GO:0045743) |
0.9 | 6.0 | GO:0046208 | spermine catabolic process(GO:0046208) |
0.8 | 4.0 | GO:0038094 | Fc-gamma receptor signaling pathway(GO:0038094) |
0.8 | 3.1 | GO:0002767 | immune response-inhibiting cell surface receptor signaling pathway(GO:0002767) |
0.7 | 3.6 | GO:0051902 | negative regulation of mitochondrial depolarization(GO:0051902) |
0.7 | 2.1 | GO:0032972 | regulation of muscle filament sliding speed(GO:0032972) |
0.7 | 2.0 | GO:0045004 | DNA replication proofreading(GO:0045004) |
0.6 | 1.8 | GO:2000620 | positive regulation of histone H4-K16 acetylation(GO:2000620) |
0.6 | 1.2 | GO:0035723 | interleukin-15-mediated signaling pathway(GO:0035723) cellular response to interleukin-15(GO:0071350) |
0.5 | 3.3 | GO:0002457 | T cell antigen processing and presentation(GO:0002457) |
0.5 | 2.1 | GO:0071608 | macrophage inflammatory protein-1 alpha production(GO:0071608) |
0.5 | 2.1 | GO:0038183 | regulation of vitamin D 24-hydroxylase activity(GO:0010979) positive regulation of vitamin D 24-hydroxylase activity(GO:0010980) bile acid signaling pathway(GO:0038183) |
0.5 | 5.8 | GO:0034242 | negative regulation of syncytium formation by plasma membrane fusion(GO:0034242) |
0.4 | 5.7 | GO:0060352 | cell adhesion molecule production(GO:0060352) |
0.4 | 1.6 | GO:0015801 | aromatic amino acid transport(GO:0015801) tryptophan transport(GO:0015827) positive regulation of gap junction assembly(GO:1903598) |
0.4 | 3.1 | GO:0015919 | peroxisomal membrane transport(GO:0015919) protein import into peroxisome membrane(GO:0045046) |
0.3 | 1.7 | GO:0002121 | inter-male aggressive behavior(GO:0002121) |
0.3 | 1.7 | GO:0014022 | neural plate elongation(GO:0014022) convergent extension involved in neural plate elongation(GO:0022007) |
0.3 | 2.2 | GO:0072321 | chaperone-mediated protein transport(GO:0072321) |
0.3 | 4.3 | GO:0051574 | positive regulation of histone H3-K9 methylation(GO:0051574) |
0.3 | 0.8 | GO:0090076 | relaxation of skeletal muscle(GO:0090076) |
0.3 | 0.8 | GO:0048866 | endodermal cell fate determination(GO:0007493) stem cell fate specification(GO:0048866) regulation of transcription involved in primary germ layer cell fate commitment(GO:0060796) regulation of cardiac cell fate specification(GO:2000043) |
0.3 | 1.8 | GO:0006621 | protein retention in ER lumen(GO:0006621) |
0.3 | 3.1 | GO:1902083 | negative regulation of peptidyl-cysteine S-nitrosylation(GO:1902083) |
0.3 | 0.8 | GO:0090285 | negative regulation of protein glycosylation in Golgi(GO:0090285) |
0.2 | 1.2 | GO:0001830 | trophectodermal cell fate commitment(GO:0001830) |
0.2 | 0.7 | GO:0000066 | mitochondrial ornithine transport(GO:0000066) |
0.2 | 1.2 | GO:0060313 | negative regulation of neutrophil degranulation(GO:0043314) negative regulation of blood vessel remodeling(GO:0060313) |
0.2 | 7.0 | GO:0008340 | determination of adult lifespan(GO:0008340) |
0.2 | 0.9 | GO:1903028 | asymmetric Golgi ribbon formation(GO:0090164) regulation of opsonization(GO:1903027) positive regulation of opsonization(GO:1903028) |
0.2 | 5.0 | GO:0038065 | collagen-activated signaling pathway(GO:0038065) |
0.2 | 1.1 | GO:0061086 | negative regulation of histone H3-K27 methylation(GO:0061086) |
0.2 | 1.1 | GO:0000103 | sulfate assimilation(GO:0000103) |
0.2 | 3.3 | GO:0071688 | striated muscle myosin thick filament assembly(GO:0071688) |
0.2 | 4.6 | GO:0050774 | negative regulation of dendrite morphogenesis(GO:0050774) |
0.2 | 1.0 | GO:0002282 | microglial cell activation involved in immune response(GO:0002282) |
0.2 | 3.7 | GO:0001833 | inner cell mass cell proliferation(GO:0001833) |
0.2 | 1.9 | GO:0030886 | negative regulation of myeloid dendritic cell activation(GO:0030886) |
0.2 | 3.1 | GO:0014883 | transition between fast and slow fiber(GO:0014883) |
0.2 | 1.5 | GO:0001915 | negative regulation of T cell mediated cytotoxicity(GO:0001915) |
0.2 | 1.1 | GO:0002430 | complement receptor mediated signaling pathway(GO:0002430) |
0.2 | 1.8 | GO:0042983 | very-low-density lipoprotein particle assembly(GO:0034379) amyloid precursor protein biosynthetic process(GO:0042983) regulation of amyloid precursor protein biosynthetic process(GO:0042984) |
0.2 | 1.9 | GO:0007221 | positive regulation of transcription of Notch receptor target(GO:0007221) |
0.2 | 1.3 | GO:0031087 | deadenylation-independent decapping of nuclear-transcribed mRNA(GO:0031087) |
0.2 | 1.2 | GO:1903056 | regulation of melanosome organization(GO:1903056) |
0.2 | 2.0 | GO:0048304 | positive regulation of isotype switching to IgG isotypes(GO:0048304) |
0.2 | 3.3 | GO:0002726 | positive regulation of T cell cytokine production(GO:0002726) |
0.2 | 0.8 | GO:1903527 | positive regulation of membrane tubulation(GO:1903527) |
0.2 | 0.8 | GO:2000434 | regulation of protein neddylation(GO:2000434) negative regulation of protein neddylation(GO:2000435) |
0.2 | 0.8 | GO:2000622 | regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000622) negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000623) |
0.2 | 2.0 | GO:0035970 | peptidyl-threonine dephosphorylation(GO:0035970) |
0.2 | 2.5 | GO:0000188 | inactivation of MAPK activity(GO:0000188) |
0.2 | 1.8 | GO:0032836 | glomerular basement membrane development(GO:0032836) |
0.1 | 2.1 | GO:0016998 | cell wall macromolecule catabolic process(GO:0016998) |
0.1 | 2.0 | GO:0035872 | nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway(GO:0035872) |
0.1 | 8.2 | GO:1900026 | positive regulation of substrate adhesion-dependent cell spreading(GO:1900026) |
0.1 | 0.1 | GO:0032805 | positive regulation of low-density lipoprotein particle receptor catabolic process(GO:0032805) |
0.1 | 0.5 | GO:0048687 | positive regulation of sprouting of injured axon(GO:0048687) positive regulation of axon extension involved in regeneration(GO:0048691) |
0.1 | 0.6 | GO:0007089 | traversing start control point of mitotic cell cycle(GO:0007089) |
0.1 | 0.4 | GO:1902915 | negative regulation of protein K63-linked ubiquitination(GO:1900045) negative regulation of protein polyubiquitination(GO:1902915) |
0.1 | 0.6 | GO:0035616 | histone H2B conserved C-terminal lysine deubiquitination(GO:0035616) |
0.1 | 7.1 | GO:1902476 | chloride transmembrane transport(GO:1902476) |
0.1 | 0.3 | GO:1904798 | positive regulation of core promoter binding(GO:1904798) |
0.1 | 1.5 | GO:0015747 | urate transport(GO:0015747) |
0.1 | 0.6 | GO:0098838 | reduced folate transmembrane transport(GO:0098838) |
0.1 | 0.6 | GO:0010735 | positive regulation of transcription via serum response element binding(GO:0010735) |
0.1 | 0.3 | GO:0036363 | transforming growth factor beta activation(GO:0036363) regulation of mesenchymal stem cell proliferation(GO:1902460) positive regulation of mesenchymal stem cell proliferation(GO:1902462) |
0.1 | 0.7 | GO:0050861 | positive regulation of B cell receptor signaling pathway(GO:0050861) |
0.1 | 0.7 | GO:0003350 | pulmonary myocardium development(GO:0003350) dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) |
0.1 | 2.4 | GO:0006301 | postreplication repair(GO:0006301) |
0.1 | 0.3 | GO:1900126 | negative regulation of hyaluronan biosynthetic process(GO:1900126) |
0.1 | 0.3 | GO:0071034 | CUT catabolic process(GO:0071034) CUT metabolic process(GO:0071043) polyadenylation-dependent snoRNA 3'-end processing(GO:0071051) |
0.1 | 1.2 | GO:0061072 | iris morphogenesis(GO:0061072) |
0.1 | 1.2 | GO:0090266 | regulation of mitotic cell cycle spindle assembly checkpoint(GO:0090266) regulation of mitotic spindle checkpoint(GO:1903504) |
0.1 | 2.0 | GO:0001553 | luteinization(GO:0001553) |
0.1 | 0.5 | GO:1990481 | mRNA pseudouridine synthesis(GO:1990481) |
0.1 | 1.7 | GO:0050765 | negative regulation of phagocytosis(GO:0050765) |
0.1 | 7.5 | GO:0042100 | B cell proliferation(GO:0042100) |
0.1 | 0.2 | GO:0040010 | positive regulation of growth rate(GO:0040010) |
0.1 | 0.4 | GO:0031584 | activation of phospholipase D activity(GO:0031584) |
0.1 | 1.6 | GO:0009950 | dorsal/ventral axis specification(GO:0009950) trophoblast giant cell differentiation(GO:0060707) |
0.1 | 0.5 | GO:0071883 | activation of MAPK activity by adrenergic receptor signaling pathway(GO:0071883) adrenergic receptor signaling pathway involved in heart process(GO:0086023) |
0.1 | 0.2 | GO:0006438 | valyl-tRNA aminoacylation(GO:0006438) |
0.1 | 0.1 | GO:0055099 | response to high density lipoprotein particle(GO:0055099) |
0.1 | 0.2 | GO:0046370 | fructose biosynthetic process(GO:0046370) |
0.1 | 0.4 | GO:0035372 | protein localization to microtubule(GO:0035372) |
0.1 | 1.3 | GO:0033235 | positive regulation of protein sumoylation(GO:0033235) |
0.0 | 0.6 | GO:0000712 | resolution of meiotic recombination intermediates(GO:0000712) |
0.0 | 2.4 | GO:0006182 | cGMP biosynthetic process(GO:0006182) |
0.0 | 0.6 | GO:0072540 | T-helper 17 cell lineage commitment(GO:0072540) |
0.0 | 0.5 | GO:2000766 | negative regulation of cytoplasmic translation(GO:2000766) |
0.0 | 0.2 | GO:0060398 | regulation of growth hormone receptor signaling pathway(GO:0060398) |
0.0 | 2.5 | GO:0070830 | bicellular tight junction assembly(GO:0070830) |
0.0 | 1.5 | GO:0007340 | acrosome reaction(GO:0007340) |
0.0 | 2.2 | GO:0045737 | positive regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0045737) |
0.0 | 0.9 | GO:0048312 | intracellular distribution of mitochondria(GO:0048312) |
0.0 | 1.9 | GO:2000401 | regulation of lymphocyte migration(GO:2000401) |
0.0 | 0.3 | GO:0061635 | regulation of protein complex stability(GO:0061635) |
0.0 | 0.4 | GO:0043353 | enucleate erythrocyte differentiation(GO:0043353) |
0.0 | 1.1 | GO:0044253 | positive regulation of collagen metabolic process(GO:0010714) positive regulation of collagen biosynthetic process(GO:0032967) positive regulation of multicellular organismal metabolic process(GO:0044253) |
0.0 | 0.8 | GO:0002495 | antigen processing and presentation of peptide antigen via MHC class II(GO:0002495) |
0.0 | 3.5 | GO:0030148 | sphingolipid biosynthetic process(GO:0030148) |
0.0 | 1.5 | GO:0010972 | negative regulation of G2/M transition of mitotic cell cycle(GO:0010972) |
0.0 | 0.2 | GO:1902167 | positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator(GO:1902167) |
0.0 | 1.0 | GO:0030865 | cortical cytoskeleton organization(GO:0030865) |
0.0 | 1.1 | GO:0050482 | arachidonic acid secretion(GO:0050482) arachidonate transport(GO:1903963) |
0.0 | 0.4 | GO:0090110 | cargo loading into COPII-coated vesicle(GO:0090110) |
0.0 | 0.4 | GO:0030953 | astral microtubule organization(GO:0030953) |
0.0 | 0.4 | GO:0044406 | adhesion of symbiont to host(GO:0044406) |
0.0 | 0.9 | GO:0010614 | negative regulation of cardiac muscle hypertrophy(GO:0010614) |
0.0 | 0.8 | GO:0043457 | regulation of cellular respiration(GO:0043457) |
0.0 | 0.3 | GO:2001269 | negative regulation by host of viral transcription(GO:0043922) positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001269) |
0.0 | 0.1 | GO:0048254 | snoRNA localization(GO:0048254) |
0.0 | 0.1 | GO:0015808 | L-alanine transport(GO:0015808) |
0.0 | 1.7 | GO:0055013 | cardiac muscle cell development(GO:0055013) |
0.0 | 1.0 | GO:0043392 | negative regulation of DNA binding(GO:0043392) |
0.0 | 0.2 | GO:0008090 | retrograde axonal transport(GO:0008090) |
0.0 | 0.1 | GO:0045218 | zonula adherens maintenance(GO:0045218) |
0.0 | 0.4 | GO:1903427 | negative regulation of reactive oxygen species biosynthetic process(GO:1903427) |
0.0 | 0.1 | GO:0070933 | histone H4 deacetylation(GO:0070933) |
0.0 | 0.6 | GO:0033209 | tumor necrosis factor-mediated signaling pathway(GO:0033209) |
0.0 | 0.4 | GO:0000184 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:0000184) |
0.0 | 0.5 | GO:0006376 | mRNA splice site selection(GO:0006376) |
0.0 | 0.1 | GO:0001771 | immunological synapse formation(GO:0001771) |
0.0 | 1.2 | GO:0090630 | activation of GTPase activity(GO:0090630) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.1 | 14.6 | GO:0031232 | extrinsic component of external side of plasma membrane(GO:0031232) |
1.0 | 9.5 | GO:0042581 | specific granule(GO:0042581) |
0.9 | 15.0 | GO:0005766 | primary lysosome(GO:0005766) azurophil granule(GO:0042582) |
0.4 | 2.0 | GO:0008622 | epsilon DNA polymerase complex(GO:0008622) |
0.4 | 2.2 | GO:0030670 | phagocytic vesicle membrane(GO:0030670) |
0.3 | 2.1 | GO:0001651 | dense fibrillar component(GO:0001651) |
0.3 | 2.1 | GO:1990584 | cardiac Troponin complex(GO:1990584) |
0.3 | 2.4 | GO:0030915 | Smc5-Smc6 complex(GO:0030915) |
0.3 | 3.6 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
0.3 | 1.7 | GO:0048237 | rough endoplasmic reticulum lumen(GO:0048237) |
0.3 | 4.0 | GO:0000778 | condensed nuclear chromosome kinetochore(GO:0000778) |
0.3 | 1.3 | GO:0000120 | RNA polymerase I transcription factor complex(GO:0000120) |
0.3 | 8.0 | GO:0031307 | integral component of mitochondrial outer membrane(GO:0031307) |
0.3 | 3.1 | GO:0005861 | troponin complex(GO:0005861) |
0.2 | 0.6 | GO:0032127 | dense core granule membrane(GO:0032127) |
0.2 | 3.1 | GO:0051286 | cell tip(GO:0051286) |
0.2 | 5.4 | GO:0035098 | ESC/E(Z) complex(GO:0035098) |
0.2 | 1.2 | GO:0045009 | melanosome membrane(GO:0033162) chitosome(GO:0045009) |
0.2 | 5.2 | GO:0097228 | sperm principal piece(GO:0097228) |
0.1 | 4.0 | GO:0001891 | phagocytic cup(GO:0001891) |
0.1 | 0.8 | GO:0031314 | extrinsic component of mitochondrial inner membrane(GO:0031314) |
0.1 | 2.3 | GO:0017146 | NMDA selective glutamate receptor complex(GO:0017146) |
0.1 | 8.3 | GO:0031985 | Golgi cisterna(GO:0031985) |
0.1 | 7.0 | GO:0034707 | chloride channel complex(GO:0034707) |
0.1 | 3.5 | GO:0051233 | spindle midzone(GO:0051233) |
0.1 | 5.6 | GO:0031901 | early endosome membrane(GO:0031901) |
0.1 | 2.7 | GO:0032982 | muscle myosin complex(GO:0005859) myosin filament(GO:0032982) |
0.1 | 1.0 | GO:0031080 | nuclear pore outer ring(GO:0031080) |
0.1 | 2.4 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
0.1 | 1.0 | GO:0097208 | alveolar lamellar body(GO:0097208) |
0.1 | 1.8 | GO:0005605 | basal lamina(GO:0005605) |
0.1 | 1.8 | GO:0043196 | varicosity(GO:0043196) |
0.1 | 0.9 | GO:0031315 | extrinsic component of mitochondrial outer membrane(GO:0031315) |
0.1 | 5.0 | GO:0022625 | cytosolic large ribosomal subunit(GO:0022625) |
0.1 | 0.6 | GO:0043240 | Fanconi anaemia nuclear complex(GO:0043240) |
0.1 | 0.3 | GO:0097550 | transcriptional preinitiation complex(GO:0097550) |
0.1 | 0.3 | GO:0031523 | Myb complex(GO:0031523) |
0.1 | 1.7 | GO:0032809 | neuronal cell body membrane(GO:0032809) |
0.1 | 1.3 | GO:1990124 | messenger ribonucleoprotein complex(GO:1990124) |
0.0 | 1.7 | GO:0032590 | dendrite membrane(GO:0032590) |
0.0 | 0.1 | GO:1990667 | PCSK9-AnxA2 complex(GO:1990667) |
0.0 | 0.4 | GO:0016460 | myosin II complex(GO:0016460) |
0.0 | 0.4 | GO:0031254 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
0.0 | 8.1 | GO:0005903 | brush border(GO:0005903) |
0.0 | 2.3 | GO:0000307 | cyclin-dependent protein kinase holoenzyme complex(GO:0000307) |
0.0 | 0.7 | GO:0005665 | DNA-directed RNA polymerase II, core complex(GO:0005665) |
0.0 | 0.2 | GO:0031673 | H zone(GO:0031673) |
0.0 | 6.5 | GO:0032993 | protein-DNA complex(GO:0032993) |
0.0 | 0.4 | GO:0030127 | COPII vesicle coat(GO:0030127) |
0.0 | 5.7 | GO:0005769 | early endosome(GO:0005769) |
0.0 | 0.3 | GO:0000177 | cytoplasmic exosome (RNase complex)(GO:0000177) |
0.0 | 0.8 | GO:0002102 | podosome(GO:0002102) |
0.0 | 0.6 | GO:0001741 | XY body(GO:0001741) |
0.0 | 2.1 | GO:0016605 | PML body(GO:0016605) |
0.0 | 0.1 | GO:0033553 | rDNA heterochromatin(GO:0033553) |
0.0 | 5.9 | GO:0031965 | nuclear membrane(GO:0031965) |
0.0 | 0.8 | GO:0005790 | smooth endoplasmic reticulum(GO:0005790) |
0.0 | 1.1 | GO:0022627 | cytosolic small ribosomal subunit(GO:0022627) |
0.0 | 0.5 | GO:0005680 | anaphase-promoting complex(GO:0005680) |
0.0 | 0.8 | GO:0031201 | SNARE complex(GO:0031201) |
0.0 | 0.2 | GO:0017101 | aminoacyl-tRNA synthetase multienzyme complex(GO:0017101) |
0.0 | 0.4 | GO:0005682 | U5 snRNP(GO:0005682) |
0.0 | 1.3 | GO:0032587 | ruffle membrane(GO:0032587) |
0.0 | 0.1 | GO:0005915 | zonula adherens(GO:0005915) |
0.0 | 2.1 | GO:0005923 | bicellular tight junction(GO:0005923) |
0.0 | 1.5 | GO:0000932 | cytoplasmic mRNA processing body(GO:0000932) |
0.0 | 0.1 | GO:0070761 | pre-snoRNP complex(GO:0070761) |
0.0 | 2.6 | GO:0012506 | vesicle membrane(GO:0012506) |
0.0 | 0.6 | GO:0005844 | polysome(GO:0005844) |
0.0 | 1.8 | GO:0005875 | microtubule associated complex(GO:0005875) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
3.3 | 13.2 | GO:0015057 | thrombin receptor activity(GO:0015057) |
2.0 | 6.0 | GO:0046592 | polyamine oxidase activity(GO:0046592) spermine:oxygen oxidoreductase (spermidine-forming) activity(GO:0052901) |
1.9 | 5.7 | GO:0003829 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity(GO:0003829) |
1.6 | 14.6 | GO:0033691 | sialic acid binding(GO:0033691) |
1.2 | 3.5 | GO:0047256 | beta-galactosyl-N-acetylglucosaminylgalactosylglucosyl-ceramide beta-1,3-acetylglucosaminyltransferase activity(GO:0008457) lactosylceramide 1,3-N-acetyl-beta-D-glucosaminyltransferase activity(GO:0047256) |
0.9 | 4.7 | GO:0042895 | antibiotic transporter activity(GO:0042895) |
0.9 | 2.7 | GO:0031751 | D4 dopamine receptor binding(GO:0031751) |
0.8 | 5.4 | GO:0032027 | myosin light chain binding(GO:0032027) |
0.7 | 2.1 | GO:1902271 | lithocholic acid binding(GO:1902121) D3 vitamins binding(GO:1902271) |
0.6 | 1.9 | GO:0004909 | interleukin-1, Type I, activating receptor activity(GO:0004909) |
0.6 | 2.3 | GO:0061575 | cyclin-dependent protein serine/threonine kinase activator activity(GO:0061575) |
0.5 | 2.0 | GO:0004741 | [pyruvate dehydrogenase (lipoamide)] phosphatase activity(GO:0004741) |
0.5 | 1.8 | GO:0046923 | ER retention sequence binding(GO:0046923) |
0.4 | 15.3 | GO:0043539 | protein serine/threonine kinase activator activity(GO:0043539) |
0.4 | 3.1 | GO:0004035 | alkaline phosphatase activity(GO:0004035) |
0.4 | 3.1 | GO:0030911 | TPR domain binding(GO:0030911) |
0.4 | 2.2 | GO:0042731 | PH domain binding(GO:0042731) |
0.4 | 2.2 | GO:0097001 | ceramide binding(GO:0097001) |
0.3 | 1.7 | GO:0019960 | C-X3-C chemokine binding(GO:0019960) |
0.3 | 10.6 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
0.3 | 2.1 | GO:0031013 | troponin I binding(GO:0031013) |
0.3 | 2.3 | GO:0050786 | RAGE receptor binding(GO:0050786) |
0.3 | 0.8 | GO:0071633 | dihydroceramidase activity(GO:0071633) |
0.3 | 2.0 | GO:0008310 | single-stranded DNA 3'-5' exodeoxyribonuclease activity(GO:0008310) |
0.2 | 15.0 | GO:0004601 | peroxidase activity(GO:0004601) |
0.2 | 1.6 | GO:0008241 | peptidyl-dipeptidase activity(GO:0008241) |
0.2 | 0.9 | GO:0036313 | phosphatidylinositol 3-kinase catalytic subunit binding(GO:0036313) |
0.2 | 6.9 | GO:0017134 | fibroblast growth factor binding(GO:0017134) |
0.2 | 10.0 | GO:0050699 | WW domain binding(GO:0050699) |
0.2 | 0.4 | GO:0031752 | D5 dopamine receptor binding(GO:0031752) |
0.2 | 1.7 | GO:0019992 | diacylglycerol binding(GO:0019992) |
0.2 | 1.1 | GO:0004027 | alcohol sulfotransferase activity(GO:0004027) |
0.1 | 2.1 | GO:0003796 | lysozyme activity(GO:0003796) |
0.1 | 2.4 | GO:0004016 | adenylate cyclase activity(GO:0004016) |
0.1 | 1.2 | GO:0035240 | dopamine binding(GO:0035240) |
0.1 | 0.7 | GO:0000064 | L-ornithine transmembrane transporter activity(GO:0000064) |
0.1 | 2.7 | GO:0097493 | structural molecule activity conferring elasticity(GO:0097493) |
0.1 | 0.1 | GO:0034189 | very-low-density lipoprotein particle binding(GO:0034189) |
0.1 | 0.6 | GO:0051373 | FATZ binding(GO:0051373) |
0.1 | 5.9 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
0.1 | 2.3 | GO:0030215 | semaphorin receptor binding(GO:0030215) |
0.1 | 3.2 | GO:0001968 | fibronectin binding(GO:0001968) |
0.1 | 3.5 | GO:0008574 | ATP-dependent microtubule motor activity, plus-end-directed(GO:0008574) |
0.1 | 3.3 | GO:0043274 | phospholipase binding(GO:0043274) |
0.1 | 0.6 | GO:0008518 | reduced folate carrier activity(GO:0008518) |
0.1 | 0.8 | GO:0043237 | laminin-1 binding(GO:0043237) |
0.1 | 1.4 | GO:0001164 | RNA polymerase I regulatory region sequence-specific DNA binding(GO:0001163) RNA polymerase I CORE element sequence-specific DNA binding(GO:0001164) |
0.1 | 4.3 | GO:0032452 | histone demethylase activity(GO:0032452) |
0.1 | 0.8 | GO:0055104 | ligase inhibitor activity(GO:0055104) ubiquitin ligase inhibitor activity(GO:1990948) |
0.1 | 0.5 | GO:0005030 | neurotrophin receptor activity(GO:0005030) |
0.1 | 0.8 | GO:0086008 | voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization(GO:0086008) |
0.1 | 3.4 | GO:0032266 | phosphatidylinositol-3-phosphate binding(GO:0032266) |
0.1 | 3.7 | GO:0005044 | scavenger receptor activity(GO:0005044) |
0.1 | 0.9 | GO:0051371 | muscle alpha-actinin binding(GO:0051371) |
0.1 | 6.0 | GO:0097110 | scaffold protein binding(GO:0097110) |
0.1 | 1.3 | GO:0031681 | G-protein beta-subunit binding(GO:0031681) |
0.1 | 0.7 | GO:0001055 | RNA polymerase II activity(GO:0001055) |
0.1 | 2.5 | GO:0042805 | actinin binding(GO:0042805) |
0.1 | 1.0 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
0.1 | 0.9 | GO:0004439 | phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity(GO:0004439) |
0.1 | 0.6 | GO:0050700 | CARD domain binding(GO:0050700) |
0.1 | 1.4 | GO:0008266 | poly(U) RNA binding(GO:0008266) |
0.1 | 0.2 | GO:0034437 | glycoprotein transporter activity(GO:0034437) |
0.1 | 0.1 | GO:0034617 | nitric-oxide synthase activity(GO:0004517) tetrahydrobiopterin binding(GO:0034617) |
0.1 | 0.2 | GO:0004832 | valine-tRNA ligase activity(GO:0004832) |
0.1 | 2.5 | GO:0042169 | SH2 domain binding(GO:0042169) |
0.1 | 0.5 | GO:0004691 | cAMP-dependent protein kinase activity(GO:0004691) |
0.1 | 0.6 | GO:0008526 | phosphatidylinositol transporter activity(GO:0008526) |
0.1 | 3.3 | GO:0030374 | ligand-dependent nuclear receptor transcription coactivator activity(GO:0030374) |
0.1 | 0.3 | GO:0070180 | large ribosomal subunit rRNA binding(GO:0070180) |
0.0 | 0.3 | GO:0032051 | clathrin light chain binding(GO:0032051) |
0.0 | 1.4 | GO:0000062 | fatty-acyl-CoA binding(GO:0000062) |
0.0 | 0.1 | GO:0005302 | L-tyrosine transmembrane transporter activity(GO:0005302) |
0.0 | 1.2 | GO:0046966 | thyroid hormone receptor binding(GO:0046966) |
0.0 | 0.6 | GO:0030247 | pattern binding(GO:0001871) polysaccharide binding(GO:0030247) |
0.0 | 0.6 | GO:0043522 | leucine zipper domain binding(GO:0043522) |
0.0 | 1.0 | GO:0035591 | signaling adaptor activity(GO:0035591) |
0.0 | 0.5 | GO:0000900 | translation repressor activity, nucleic acid binding(GO:0000900) |
0.0 | 1.6 | GO:0004864 | protein phosphatase inhibitor activity(GO:0004864) |
0.0 | 0.2 | GO:0004342 | glucosamine-6-phosphate deaminase activity(GO:0004342) |
0.0 | 0.5 | GO:0009982 | pseudouridine synthase activity(GO:0009982) |
0.0 | 1.1 | GO:0004623 | phospholipase A2 activity(GO:0004623) |
0.0 | 0.9 | GO:0005035 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
0.0 | 1.9 | GO:0015179 | L-amino acid transmembrane transporter activity(GO:0015179) |
0.0 | 0.8 | GO:0042287 | MHC protein binding(GO:0042287) |
0.0 | 2.4 | GO:0005254 | chloride channel activity(GO:0005254) |
0.0 | 7.3 | GO:0003924 | GTPase activity(GO:0003924) |
0.0 | 0.2 | GO:0016724 | ferroxidase activity(GO:0004322) oxidoreductase activity, oxidizing metal ions, oxygen as acceptor(GO:0016724) |
0.0 | 0.2 | GO:0052851 | ferric-chelate reductase activity(GO:0000293) cupric reductase activity(GO:0008823) ferric-chelate reductase (NADPH) activity(GO:0052851) |
0.0 | 0.3 | GO:0008179 | adenylate cyclase binding(GO:0008179) |
0.0 | 0.2 | GO:0017075 | syntaxin-1 binding(GO:0017075) |
0.0 | 0.7 | GO:0005452 | inorganic anion exchanger activity(GO:0005452) |
0.0 | 0.2 | GO:0070273 | phosphatidylinositol-4-phosphate binding(GO:0070273) |
0.0 | 2.4 | GO:0005525 | GTP binding(GO:0005525) |
0.0 | 1.1 | GO:0035064 | methylated histone binding(GO:0035064) |
0.0 | 0.1 | GO:0001094 | TFIID-class transcription factor binding(GO:0001094) |
0.0 | 5.9 | GO:0045296 | cadherin binding(GO:0045296) |
0.0 | 0.9 | GO:0030507 | spectrin binding(GO:0030507) |
0.0 | 1.2 | GO:0048306 | calcium-dependent protein binding(GO:0048306) |
0.0 | 0.2 | GO:0050692 | DBD domain binding(GO:0050692) |
0.0 | 0.1 | GO:0016004 | phospholipase activator activity(GO:0016004) |
0.0 | 0.1 | GO:0019788 | NEDD8 transferase activity(GO:0019788) |
0.0 | 0.0 | GO:0004487 | methylenetetrahydrofolate dehydrogenase (NAD+) activity(GO:0004487) |
0.0 | 0.1 | GO:0070097 | delta-catenin binding(GO:0070097) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.6 | 11.4 | PID THROMBIN PAR4 PATHWAY | PAR4-mediated thrombin signaling events |
0.3 | 17.1 | PID IL23 PATHWAY | IL23-mediated signaling events |
0.2 | 9.2 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
0.2 | 15.3 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
0.1 | 1.5 | PID PI3KCI PATHWAY | Class I PI3K signaling events |
0.1 | 4.7 | PID ARF6 PATHWAY | Arf6 signaling events |
0.1 | 1.8 | ST JAK STAT PATHWAY | Jak-STAT Pathway |
0.1 | 2.4 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
0.1 | 1.1 | PID UPA UPAR PATHWAY | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling |
0.1 | 4.4 | PID RHOA PATHWAY | RhoA signaling pathway |
0.0 | 2.3 | PID FOXM1 PATHWAY | FOXM1 transcription factor network |
0.0 | 1.6 | PID CD40 PATHWAY | CD40/CD40L signaling |
0.0 | 0.8 | PID ARF 3PATHWAY | Arf1 pathway |
0.0 | 1.8 | NABA BASEMENT MEMBRANES | Genes encoding structural components of basement membranes |
0.0 | 3.2 | PID ERA GENOMIC PATHWAY | Validated nuclear estrogen receptor alpha network |
0.0 | 2.1 | PID RETINOIC ACID PATHWAY | Retinoic acid receptors-mediated signaling |
0.0 | 3.0 | PID RAC1 REG PATHWAY | Regulation of RAC1 activity |
0.0 | 0.2 | PID IL12 STAT4 PATHWAY | IL12 signaling mediated by STAT4 |
0.0 | 6.7 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
0.0 | 1.4 | PID P53 REGULATION PATHWAY | p53 pathway |
0.0 | 2.3 | PID CMYB PATHWAY | C-MYB transcription factor network |
0.0 | 0.5 | PID THROMBIN PAR1 PATHWAY | PAR1-mediated thrombin signaling events |
0.0 | 1.3 | PID P73PATHWAY | p73 transcription factor network |
0.0 | 0.4 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
0.0 | 0.6 | PID FANCONI PATHWAY | Fanconi anemia pathway |
0.0 | 0.2 | SA B CELL RECEPTOR COMPLEXES | Antigen binding to B cell receptors activates protein tyrosine kinases, such as the Src family, which ultimate activate MAP kinases. |
0.0 | 1.4 | PID P53 DOWNSTREAM PATHWAY | Direct p53 effectors |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.3 | 5.4 | REACTOME BINDING AND ENTRY OF HIV VIRION | Genes involved in Binding and entry of HIV virion |
0.7 | 15.3 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.4 | 6.0 | REACTOME METABOLISM OF POLYAMINES | Genes involved in Metabolism of polyamines |
0.2 | 11.2 | REACTOME THROMBIN SIGNALLING THROUGH PROTEINASE ACTIVATED RECEPTORS PARS | Genes involved in Thrombin signalling through proteinase activated receptors (PARs) |
0.2 | 2.1 | REACTOME THE NLRP3 INFLAMMASOME | Genes involved in The NLRP3 inflammasome |
0.2 | 2.4 | REACTOME ADENYLATE CYCLASE ACTIVATING PATHWAY | Genes involved in Adenylate cyclase activating pathway |
0.2 | 2.0 | REACTOME REGULATION OF PYRUVATE DEHYDROGENASE PDH COMPLEX | Genes involved in Regulation of pyruvate dehydrogenase (PDH) complex |
0.1 | 8.7 | REACTOME O LINKED GLYCOSYLATION OF MUCINS | Genes involved in O-linked glycosylation of mucins |
0.1 | 2.1 | REACTOME REPAIR SYNTHESIS FOR GAP FILLING BY DNA POL IN TC NER | Genes involved in Repair synthesis for gap-filling by DNA polymerase in TC-NER |
0.1 | 3.2 | REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX | Genes involved in Degradation of the extracellular matrix |
0.1 | 1.9 | REACTOME NOTCH HLH TRANSCRIPTION PATHWAY | Genes involved in Notch-HLH transcription pathway |
0.1 | 5.8 | REACTOME STRIATED MUSCLE CONTRACTION | Genes involved in Striated Muscle Contraction |
0.1 | 1.1 | REACTOME CYTOSOLIC SULFONATION OF SMALL MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
0.1 | 1.3 | REACTOME MRNA DECAY BY 5 TO 3 EXORIBONUCLEASE | Genes involved in mRNA Decay by 5' to 3' Exoribonuclease |
0.1 | 4.0 | REACTOME DEPOSITION OF NEW CENPA CONTAINING NUCLEOSOMES AT THE CENTROMERE | Genes involved in Deposition of New CENPA-containing Nucleosomes at the Centromere |
0.1 | 1.1 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
0.1 | 1.1 | REACTOME ACYL CHAIN REMODELLING OF PS | Genes involved in Acyl chain remodelling of PS |
0.0 | 2.3 | REACTOME G1 PHASE | Genes involved in G1 Phase |
0.0 | 3.3 | REACTOME ACTIVATION OF THE MRNA UPON BINDING OF THE CAP BINDING COMPLEX AND EIFS AND SUBSEQUENT BINDING TO 43S | Genes involved in Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S |
0.0 | 1.0 | REACTOME RNA POL I TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase I Transcription Termination |
0.0 | 0.7 | REACTOME VIRAL MESSENGER RNA SYNTHESIS | Genes involved in Viral Messenger RNA Synthesis |
0.0 | 2.3 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
0.0 | 4.1 | REACTOME RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2 | Genes involved in Response to elevated platelet cytosolic Ca2+ |
0.0 | 0.8 | REACTOME INHIBITION OF VOLTAGE GATED CA2 CHANNELS VIA GBETA GAMMA SUBUNITS | Genes involved in Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits |
0.0 | 1.2 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
0.0 | 1.0 | REACTOME REGULATION OF GLUCOKINASE BY GLUCOKINASE REGULATORY PROTEIN | Genes involved in Regulation of Glucokinase by Glucokinase Regulatory Protein |
0.0 | 0.9 | REACTOME SIGNALING BY FGFR1 FUSION MUTANTS | Genes involved in Signaling by FGFR1 fusion mutants |
0.0 | 0.4 | REACTOME ANTIGEN PRESENTATION FOLDING ASSEMBLY AND PEPTIDE LOADING OF CLASS I MHC | Genes involved in Antigen Presentation: Folding, assembly and peptide loading of class I MHC |
0.0 | 0.6 | REACTOME FANCONI ANEMIA PATHWAY | Genes involved in Fanconi Anemia pathway |
0.0 | 0.4 | REACTOME DOPAMINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Dopamine Neurotransmitter Release Cycle |
0.0 | 1.5 | REACTOME ACTIVATION OF CHAPERONE GENES BY XBP1S | Genes involved in Activation of Chaperone Genes by XBP1(S) |
0.0 | 3.3 | REACTOME FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION | Genes involved in Factors involved in megakaryocyte development and platelet production |
0.0 | 1.5 | REACTOME PEPTIDE CHAIN ELONGATION | Genes involved in Peptide chain elongation |
0.0 | 0.2 | REACTOME CD28 DEPENDENT VAV1 PATHWAY | Genes involved in CD28 dependent Vav1 pathway |
0.0 | 0.9 | REACTOME SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE | Genes involved in Synthesis of PIPs at the plasma membrane |
0.0 | 1.7 | REACTOME NRAGE SIGNALS DEATH THROUGH JNK | Genes involved in NRAGE signals death through JNK |
0.0 | 0.4 | REACTOME NONSENSE MEDIATED DECAY ENHANCED BY THE EXON JUNCTION COMPLEX | Genes involved in Nonsense Mediated Decay Enhanced by the Exon Junction Complex |
0.0 | 0.8 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
0.0 | 0.2 | REACTOME REGULATION OF SIGNALING BY CBL | Genes involved in Regulation of signaling by CBL |
0.0 | 0.3 | REACTOME RNA POL II TRANSCRIPTION PRE INITIATION AND PROMOTER OPENING | Genes involved in RNA Polymerase II Transcription Pre-Initiation And Promoter Opening |
0.0 | 0.1 | REACTOME MRNA DECAY BY 3 TO 5 EXORIBONUCLEASE | Genes involved in mRNA Decay by 3' to 5' Exoribonuclease |
0.0 | 0.4 | REACTOME GPVI MEDIATED ACTIVATION CASCADE | Genes involved in GPVI-mediated activation cascade |